|
▽
|
APAM |
Artisan Partners Asset Manageme |
Financial Services |
12.3 |
6.4 |
32.1 |
0 |
83.6 |
13.6 |
9.3 |
3.2 |
68.6 |
-0.43 |
22.8 |
0.72 |
|
23.06 |
2024-10-24 |
| Artisan Partners Asset Management Inc. is publicly owned investment manager. It provides its services to pension and profit sharing plans, trusts, endowments, foundations, charitable organizations, government entities, private funds and non-U.S. |
|
▽
|
APD |
Air Products and Chemicals, Inc |
Basic Materials |
13.8 |
2.6 |
12.1 |
37 |
67.7 |
31.6 |
5.1 |
10.3 |
16.1 |
-10.71 |
18.3 |
1.33 |
1.17 |
44.72 |
2024-10-24 |
| Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and related services. It also designs and manufactures equipment for air separation, hydrocarbon recovery and purification, natural gas liquefaction, and |
|
▽
|
APG |
APi Group Corporation |
Industrials |
35.0 |
0.0 |
|
0 |
0.0 |
60.3 |
4.5 |
0.6 |
7.4 |
-18.07 |
2.2 |
1.43 |
1.35 |
27.29 |
2024-10-24 |
| APi Group Corporation provides safety and specialty services worldwide. It operates through Safety Services and Specialty Services segments. The Safety Services segment offers solutions focusing on end-to-end integrated occupancy systems, such as fire protection services. The Special |
|
▽
|
APGE |
Apogee Therapeutics, Inc. |
Healthcare |
|
0.0 |
|
0 |
0.0 |
-26.5 |
|
-1.9 |
|
|
|
19.38 |
|
125.40 |
2024-10-24 |
| Apogee Therapeutics, Inc. develops biologics for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily |
|
▽
|
APH |
Amphenol Corporation |
Technology |
27.9 |
0.9 |
46.6 |
12 |
26.5 |
42.8 |
9.9 |
1.6 |
23.1 |
-11.41 |
15.4 |
2.17 |
1.48 |
50.50 |
2024-10-24 |
| Amphenol Corporation designs, manufactures, and markets electrical, electronic, and fiber optic connectors in the United States, China, and internationally. It operates through three segments: Harsh Environment Solutions, Communications Solutions, and Interconnect and |
|
▽
|
APLD |
Applied Digital Corporation |
Technology |
266.3 |
0.0 |
|
0 |
0.0 |
-12.4 |
14.9 |
-0.7 |
-119.6 |
-83.70 |
|
0.08 |
|
16.36 |
2024-10-24 |
| Applied Digital Corporation designs, develops, and operates digital infrastructure solutions and cloud services high-performance computing (HPC) and artificial intelligence industries in North America. It operates through three segments: Data Center Hosting Business, Cloud Services Business |
|
▽
|
APLE |
Apple Hospitality REIT, Inc. |
Real Estate |
4.6 |
6.4 |
214.7 |
2 |
137.0 |
19.9 |
1.1 |
0.7 |
5.3 |
-22.66 |
13.2 |
0.73 |
|
67.32 |
2024-10-24 |
| Apple Hospitality REIT, Inc. is a self-advised real estate investment trust. It invests in income-producing real estate, primarily in the lodging sector, in the United States. As of March 31, 2024, the |
|
▽
|
APLS |
Apellis Pharmaceuticals, Inc. |
Healthcare |
30.6 |
0.0 |
|
0 |
0.0 |
-6.2 |
16.9 |
-4.3 |
-271.8 |
61.28 |
-133.3 |
3.10 |
2.50 |
24.66 |
2024-10-24 |
| Apellis Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system. It offers EMPAVELI for the treatment of paroxysmal nocturnal hem |
|
▽
|
APLT |
Applied Therapeutics, Inc. |
Healthcare |
43.7 |
0.0 |
|
0 |
0.0 |
-8.6 |
-60.1 |
-1.0 |
698.5 |
-100.00 |
|
0.76 |
|
-31.27 |
2024-10-24 |
| Applied Therapeutics, Inc. engages in the development of novel product candidates. The company's lead product candidate is AT-007 that has completed phase 3 for the treatment of galactosemia. It also develops AT-001 |
|
▽
|
APO |
Apollo Global Management, Inc. |
Financial Services |
34.4 |
1.8 |
20.6 |
1 |
19.1 |
16.2 |
5.8 |
8.9 |
35.9 |
-57.53 |
15.5 |
0.82 |
|
4.48 |
2024-10-24 |
| Apollo Global Management, Inc. is a private equity firm specializing in investments in credit, private equity, infrastructure, secondaries and real estate markets. The firm provides its services to endowment and sovereign wealth funds, as well as other |